MEREO BIOPHARMA GROUP PLC

Analyst Reco. Mereo BioPharma Group plc

Equities

MREO

US5894921072

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-01 EDT			5-day change	1st Jan Change
3.15 ^USD	+3.28%		+13.31%	+36.36%

05:40pm	European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading	MT
04-30	European Equities Traded in the US as American Depositary Receipts Decline	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Needham Adjusts Price Target on Mereo BioPharma to $6 From $5, Keeps Buy Rating	03-28	MT
Ultragenyx and Mereo BioPharma Announce Interim Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Setrusumab Significantly Reduced Fracture Rates in Patients with Osteogenesis Imperfecta (OI)	23-10-14	CI
Shift to Fed's Rate Hike Path, Better Outlook on UBS-Credit Suisse Deal Pushes US Equities Up	23-03-21	MT
European Equities Move Lower Following ECB Rate Hike	23-02-02	MT
SVB Securities Trims Price Target on Mereo BioPharma Group to $4 From $8, Maintains Outperform Rating	22-11-10	MT
Cantor Fitzgerald Starts Mereo BioPharma Group at Overweight With $4 Price Target	22-08-12	MT
Needham Adjusts Price Target on Mereo BioPharma Group to $5 From $10, Reiterates Buy Rating	22-06-06	MT
MEREO BIOPHARMA : BTIG Initiates Mereo BioPharma at Buy Rating With $10 Price Target	21-05-05	MT
MEREO BIOPHARMA : Needham Starts Mereo BioPharma Group at Buy With $10 Price Target	21-04-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer